Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse Microscopy, FRET) End User (Contract Research Organization, Research Institutes) - Global Forecast to 2025

生細胞画像の世界市場予測(~2025):製品別、用途別、技術別、エンドユーザー別

◆タイトル:Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse Microscopy, FRET) End User (Contract Research Organization, Research Institutes) - Global Forecast to 2025
◆商品コード:BT 3390
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年10月29日
◆ページ数:206
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は生細胞画像の世界市場が2020年18億ドルから2025年28億ドルまで、年平均8.8%成長すると予想しています。本調査レポートでは、生細胞画像の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業インサイト、製品・サービス別(機器、消耗品、ソフトウェア、サービス)分析、用途別(細胞生物、幹細胞、発生生物、創薬)分析、技術別(タイムラプス顕微鏡、蛍光共鳴エネルギー移動(FRET)、写真漂白後蛍光回復(フラップ)、ハイコンテントスクリーニング(HCS)、その他技術)分析、エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、医薬品開発業務受託機関)分析、地域別分析、競争状況、企業評価マトリックス・企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業インサイト
・生細胞画像の世界市場規模:製品・サービス別(機器、消耗品、ソフトウェア、サービス)
・生細胞画像の世界市場規模:用途別(細胞生物、幹細胞、発生生物、創薬)
・生細胞画像の世界市場規模:技術別(タイムラプス顕微鏡、蛍光共鳴エネルギー移動(FRET)、写真漂白後蛍光回復(フラップ)、ハイコンテントスクリーニング(HCS)、その他技術)
・生細胞画像の世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、医薬品開発業務受託機関)
・生細胞画像の世界市場規模:地域別
・競争状況
・企業評価マトリックス・企業情報

“The global live cell imaging market size is projected to reach USD 2.8 billion by 2025 from USD 1.8 billion in 2020, at a CAGR of 8.8% during the forecast period.”
The market for live cell imaging is driven primarily by the factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, growth in research funding, and rising government funding in regenerative medicine research. However, high cost of high-content screening systems will hinder the overall adoption of live cell imaging systems and thereby restrain market growth in the coming years.

“By instrument type, the microscopes segment holds the largest market share during the forecast period.”
Based on type, the live cell imaging instruments market is segmented into microscopes, standalone systems, cell analyzers, and accessories. The microscopes segment accounted for the largest share of the live cell imaging market in 2019. The large share of this segment can be attributed to the increasing studies into cell behavior and the need to correlate multiple events and markers with cell morphology, favorable funding scenario for R&D in microscopy, rising focus on regenerative medicine, technological advancements in microscopes, and favorable regulatory procedures to launch new instruments in the market.

“By application, the stem cells segment is expected to register the highest CAGR during the forecast period.”
Based on application, the live cell imaging market is segmented into cell biology, stem cells, developmental biology, and drug discovery. The stem cells segment is projected to register the highest CAGR during the forecast period. Factors such as the increasing stem cell research activities and investments.

“Asia Pacific (APAC) is projected to witness the highest growth during the forecast period.”
The APAC market is estimated to register the highest CAGR during the forecast period. The growth in this market can be attributed to the government initiatives for research on stem cell therapy, increasing aging population, the rising prominence of regenerative medicine research, increasing number of researchers in Japan, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea.

The breakdown of primary participants was as mentioned below:
• By Company Type: Tier 1–40%, Tier 2–35%, and Tier 3–25%
• By Designation: C-level Executives–35%, Directors–40%, and Others–25%
• By Region: North America–35%, Europe–25%, Asia Pacific–20%, Latin America–10%, Middle East & Africa–10%

The leading players in this market include Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Oxford Instruments (UK), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (Korea), Phase Focus Limited (UK), Tomocube, Inc. (South Korea), Phase Holographic Imaging PHI AB (Sweden), BD Biosciences (US), Sony Biotechnology, Inc. (US), Merck KGaA (Germany), KEYENCE Corporation (Japan), ibidi GmbH (Germany), Bio-Rad Laboratories (US), Logos Biosystems (South Korea), and Nanolive SA (Switzerland).

Research Coverage:
The report analyzes the various live cell imaging products and their adoption pattern. It aims at estimating the market size and future growth potential of the live cell imaging market for different segments such as product & service, application, technology, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their position in the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the live cell imaging market.
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the live cell imaging market.
• Market Development: Comprehensive information on the lucrative emerging regions by product, application, technology, end user, and region.
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the live cell imaging market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the live cell imaging market.

【レポートの目次】

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS & EXCLUSIONS 29
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 30
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 33
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 34
FIGURE 2 PRIMARY SOURCES 34
2.1.2.1 Key data from primary sources 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.2 MARKET SIZE ESTIMATION 36
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (ILLUSTRATIVE EXAMPLE) 36
FIGURE 6 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39
FIGURE 7 DATA TRIANGULATION METHODOLOGY 39
2.4 ASSUMPTIONS FOR THE STUDY 40
2.5 COVID-19 HEALTH ASSESSMENT 40
2.6 COVID-19 ECONOMIC ASSESSMENT 40
2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 41
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 41
FIGURE 9 SCENARIOS OF RECOVERY FROM COVID-19 IN THE GLOBAL ECONOMY 42
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO OF THE LIVE CELL IMAGING MARKET 43

3 EXECUTIVE SUMMARY 44
TABLE 1 LIVE CELL IMAGING MARKET SNAPSHOT, 2020 VS. 2025 44
FIGURE 10 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 45
FIGURE 11 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 46
FIGURE 12 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 47
FIGURE 13 LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 48
FIGURE 14 LIVE CELL IMAGING MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 49
FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 49
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE LIVE CELL IMAGING MARKET 50
4 PREMIUM INSIGHTS 52
4.1 LIVE CELL IMAGING MARKET OVERVIEW 52
FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES AND RISING INCIDENCE OF CANCER ARE KEY FACTORS DRIVING MARKET GROWTH 52
4.2 APAC: LIVE CELL IMAGING MARKET, BY APPLICATION (2019) 53
FIGURE 18 CELL BIOLOGY APPLICATIONS COMMANDED THE LARGEST SHARE OF THE APAC LIVE CELL IMAGING MARKET IN 2019 53
4.3 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 19 CHINA IS THE FASTEST-GROWING MARKET FOR LIVE CELL IMAGING 54
4.4 REGIONAL MIX: LIVE CELL IMAGING MARKET 55
FIGURE 20 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 55
4.5 LIVE CELL IMAGING MARKET: DEVELOPED VS. DEVELOPING MARKETS 56
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing adoption of high-content screening techniques in drug discovery 58
5.2.1.2 Rising incidence of cancer 58
FIGURE 22 GLOBAL CANCER INCIDENCE, 2008–2030 59
TABLE 3 GLOBAL CANCER INCIDENCE, BY REGION/COUNTRY, 2018 VS. 2030 59
5.2.1.3 Growing availability of research funds 59
5.2.1.4 Rising government funding in regenerative medicine research 60
TABLE 4 TOTAL FUNDING, BY SOURCE TYPE, 2016–2019 (USD MILLION) 60
5.2.2 RESTRAINTS 61
5.2.2.1 High cost of high-content screening systems 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Emerging markets 61
5.2.3.2 Applications of HCS in personalized medicine 62
5.2.4 CHALLENGES 62
5.2.4.1 Maintaining cell viability and the cellular environment in cell cultures 62
5.2.4.2 Dearth of skilled professionals 62
5.3 COVID-19 IMPACT ON THE LIVE CELL IMAGING MARKET 63
6 INDUSTRY INSIGHTS 64
6.1 INTRODUCTION 64
6.2 INDUSTRY TRENDS 64
6.2.1 RISING FOCUS OF MARKET PLAYERS ON ADVANCED PRODUCT LAUNCHES 64
6.2.2 GROWING ADOPTION OF LABEL-FREE TECHNOLOGIES 65
6.3 SUPPLY CHAIN ANALYSIS 65
FIGURE 23 SUPPLY CHAIN ANALYSIS: LIVE CELL IMAGING MARKET 65
6.4 VALUE CHAIN ANALYSIS 66
FIGURE 24 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS 67
7 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE 68
7.1 INTRODUCTION 69
TABLE 5 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 69
7.2 IMPACT OF COVID-19 ON THE LIVE CELL IMAGING PRODUCT & SERVICE MARKET 69
7.3 INSTRUMENTS 69
TABLE 6 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 70
TABLE 7 LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 70
7.3.1 MICROSCOPES 71
7.3.1.1 Broad applications and emerging technologies have resulted in the growing demand for microscopes 71
TABLE 8 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS 71
TABLE 9 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS 72
TABLE 10 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS 73
TABLE 11 LIVE CELL IMAGING MICROSCOPES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 74
TABLE 12 LIVE CELL IMAGING MICROSCOPES MARKET, BY REGION,
2018–2025 (UNITS) 75
7.3.2 STANDALONE SYSTEMS 75
7.3.2.1 Standalone systems provide in-depth image analysis of live cells at a faster rate—a key factor driving market growth 75
TABLE 13 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS 75
TABLE 14 LIVE CELL IMAGING STANDALONE SYSTEMS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 76
TABLE 15 LIVE CELL IMAGING STANDALONE SYSTEMS MARKET, BY REGION,
2018–2025 (UNITS) 76
7.3.3 CELL ANALYZERS 77
7.3.3.1 Players offer a wide range of cell analyzers to satisfy end-user demands 77
TABLE 16 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS 77
TABLE 17 LIVE CELL IMAGING CELL ANALYZERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 78
7.3.4 ACCESSORIES 78
7.3.4.1 Accessories find wide use in live cell image analysis 78
TABLE 18 ACCESSORIES OFFERED BY KEY MARKET PLAYERS 79
TABLE 19 LIVE CELL IMAGING ACCESSORIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 80
7.4 CONSUMABLES 80
TABLE 20 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 81
TABLE 21 LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 81
7.4.1 REAGENTS 82
7.4.1.1 Reagents have widespread usage in life sciences due to their application in various research activities 82
TABLE 22 REAGENTS OFFERED BY KEY MARKET PLAYERS 82
TABLE 23 LIVE CELL IMAGING REAGENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 83
7.4.2 ASSAY KITS 84
7.4.2.1 Repeat purchase of assay kits—a key driver for market growth 84
TABLE 24 ASSAY KITS OFFERED BY KEY MARKET PLAYERS 84
TABLE 25 LIVE CELL IMAGING ASSAY KITS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 84
7.4.3 MEDIA 85
7.4.3.1 Development of new and advanced technologies has resulted in an increased demand for high-quality media in biomedical research and processing 85
TABLE 26 MEDIA OFFERED BY KEY MARKET PLAYERS 85
TABLE 27 LIVE CELL IMAGING MEDIA MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 85
7.4.4 OTHER CONSUMABLES 86
TABLE 28 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS 86
TABLE 29 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 87
7.5 SOFTWARE 87
7.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION—
A KEY DRIVER FOR MARKET GROWTH 87
TABLE 30 SOFTWARE OFFERED BY KEY MARKET PLAYERS 88
TABLE 31 LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 89
7.6 SERVICES 89
7.6.1 AVAILABILITY OF A WIDE RANGE OF SERVICES AND GROWING NUMBER OF INITIATIVES BY KEY PLAYERS TO DRIVE THE SERVICES MARKET 89
TABLE 32 SERVICES OFFERED BY KEY MARKET PLAYERS 90
TABLE 33 LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 90
8 LIVE CELL IMAGING MARKET, BY APPLICATION 91
8.1 INTRODUCTION 92
TABLE 34 LIVE CELL IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 92
8.2 IMPACT OF COVID-19 ON THE LIVE CELL IMAGING APPLICATIONS MARKET 92
8.3 CELL BIOLOGY 93
8.3.1 INCREASING PREVALENCE OF CANCER TO DRIVE GROWTH IN THE CELL BIOLOGY APPLICATION SEGMENT 93
TABLE 35 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY, BY COUNTRY,
2018–2025 (USD MILLION) 93
8.4 STEM CELLS 94
8.4.1 IMPORTANCE OF STEM CELL RESEARCH HAS BOOSTED INVESTMENTS IN THIS AREA 94
TABLE 36 LIVE CELL IMAGING MARKET FOR STEM CELLS, BY COUNTRY,
2018–2025 (USD MILLION) 94
8.5 DEVELOPMENTAL BIOLOGY 95
8.5.1 GROWING RESEARCH IN DEVELOPMENTAL BIOLOGY—A KEY DRIVER FOR MARKET GROWTH 95
TABLE 37 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 95
8.6 DRUG DISCOVERY 96
8.6.1 USE OF HCS CELL-BASED ASSAYS HAS GROWN IN DRUG DEVELOPMENT STUDIES 96
TABLE 38 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY,
2018–2025 (USD MILLION) 96
9 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 97
9.1 INTRODUCTION 98
TABLE 39 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 98
9.2 TIME-LAPSE MICROSCOPY 98
9.2.1 GROWING NUMBER OF CELL-BASED RESEARCH ACTIVITIES WILL DRIVE THE DEMAND FOR TIME-LAPSE MICROSCOPY 98
TABLE 40 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2018–2025 (USD MILLION) 99
9.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 99
9.3.1 GROWING ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES WILL INCREASE THE ADOPTION OF FRET TECHNOLOGY 99
TABLE 41 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2018–2025 (USD MILLION) 100
9.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP) 100
9.4.1 ADVANCEMENTS IN CONFOCAL MICROSCOPY WILL SUPPORT THE MARKET GROWTH FOR FRAP 100
TABLE 42 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2018–2025 (USD MILLION) 101
9.5 HIGH-CONTENT SCREENING (HCS) 101
9.5.1 INCREASING DRUG DISCOVERY RESEARCH TO DRIVE THE GROWTH OF THIS MARKET 101
TABLE 43 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2018–2025 (USD MILLION) 102
9.6 OTHER TECHNOLOGIES 102
TABLE 44 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION) 103
10 LIVE CELL IMAGING MARKET, BY END USER 104
10.1 INTRODUCTION 105
TABLE 45 LIVE CELL IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION) 105
10.2 IMPACT OF COVID-19 ON THE LIVE CELL IMAGING END-USER MARKET 105
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 105
10.3.1 INCREASING R&D ACTIVITIES AND THE PATENT CLIFF OF VARIOUS BLOCKBUSTER DRUGS TO INCREASE THE DEMAND FOR LIVE CELL IMAGING PRODUCTS AMONG PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 105
TABLE 46 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 106
10.4 ACADEMIC & RESEARCH INSTITUTES 106
10.4.1 RISING FOCUS OF THESE END USERS ON STRENGTHENING THEIR OWN DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH 106
TABLE 47 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2018–2025 (USD MILLION) 107
10.5 CONTRACT RESEARCH ORGANIZATIONS 108
10.5.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE THE DEMAND FOR LIVE CELL IMAGING SYSTEMS AMONG CONTRACT RESEARCH ORGANIZATIONS 108
TABLE 48 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY COUNTRY, 2018–2025 (USD MILLION) 108
11 LIVE CELL IMAGING MARKET, BY REGION 109
11.1 INTRODUCTION 110
11.2 COVID-19 IMPACT ON THE LIVE CELL IMAGING MARKET 110
TABLE 49 LIVE CELL IMAGING MARKET, BY REGION, 2018–2025 (USD MILLION) 111
11.3 NORTH AMERICA 111
FIGURE 25 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT 112
TABLE 50 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 113
TABLE 51 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 113
TABLE 52 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 113
TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 114
TABLE 54 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 114
TABLE 55 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 115
TABLE 56 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 115
11.3.1 US 115
11.3.1.1 The US dominates the North American live cell imaging market primarily due to the strong trend of pharmaceutical & biotechnology research and the high burden of cancer 115
TABLE 57 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 116
TABLE 58 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 59 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 60 US: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 117
TABLE 61 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 118
TABLE 62 US: LIVE CELL IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION) 118
11.3.2 CANADA 118
11.3.2.1 Government initiatives to promote research and the need to combat cancer are the key factors driving the growth of the live cell imaging market in Canada 118
TABLE 63 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 119
TABLE 64 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 65 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 66 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 120
TABLE 67 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 121
TABLE 68 CANADA: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 121
11.4 EUROPE 121
TABLE 69 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 122
TABLE 70 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 122
TABLE 71 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 72 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 73 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 123
TABLE 74 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 124
TABLE 75 EUROPE: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 124
11.4.1 GERMANY 124
11.4.1.1 Presence of a large number of academic research institutes and increasing R&D spending to drive the demand for live cell imaging in Germany 124
TABLE 76 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 125
TABLE 77 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 78 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 79 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 126
TABLE 80 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 127
TABLE 81 GERMANY: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 127
11.4.2 UK 127
11.4.2.1 High prevalence of cancer to drive market growth in the UK 127
TABLE 82 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 128
TABLE 83 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 84 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 129
TABLE 85 UK: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 129
TABLE 86 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 129
TABLE 87 UK: LIVE CELL IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION) 130
11.4.3 FRANCE 130
11.4.3.1 Growth in the live cell imaging market in France can be attributed to the large pharmaceutical manufacturing industry and the high public expenditure on R&D 130
TABLE 88 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 131
TABLE 89 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 90 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
TABLE 91 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 132
TABLE 92 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 132
TABLE 93 FRANCE: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 133
11.4.4 REST OF EUROPE (ROE) 133
TABLE 94 ROE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 134
TABLE 95 ROE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 96 ROE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 135
TABLE 97 ROE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 135
TABLE 98 ROE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 135
TABLE 99 ROE: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 136
11.5 ASIA PACIFIC 136
FIGURE 26 ASIA PACIFIC: LIVE CELL IMAGING MARKET SNAPSHOT 137
TABLE 100 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 138
TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 138
TABLE 102 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 138
TABLE 103 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 104 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 139
TABLE 105 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 140
TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 140
11.5.1 CHINA 140
11.5.1.1 China to register the highest growth rate in the Asia Pacific live cell imaging market during the forecast period 140
TABLE 107 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 141
TABLE 108 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 141
TABLE 109 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 142
TABLE 110 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 142
TABLE 111 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 143
TABLE 112 CHINA: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 143
11.5.2 JAPAN 143
11.5.2.1 Rising prominence of regenerative medicine research and an increasing number of researchers to support market growth in Japan 143
TABLE 113 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 144
TABLE 114 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 144
TABLE 115 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
TABLE 116 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 145
TABLE 117 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 145
TABLE 118 JAPAN: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 146
11.5.3 INDIA 146
11.5.3.1 Favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry to drive market growth in India 146
TABLE 119 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 147
TABLE 120 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 121 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 122 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 148
TABLE 123 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 148
TABLE 124 INDIA: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 148
11.5.4 REST OF ASIA PACIFIC (ROAPAC) 149
TABLE 125 ROAPAC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 150
TABLE 126 ROAPAC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 127 ROAPAC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 128 ROAPAC: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 151
TABLE 129 ROAPAC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 151
TABLE 130 ROAPAC: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 151
11.6 LATIN AMERICA 152
11.6.1 MAJOR PLAYERS ESTABLISHING MANUFACTURING FACILITIES IN LATIN AMERICA TO LEVERAGE THE LOW LABOR COST—A KEY GROWTH DRIVER 152
TABLE 131 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 153
TABLE 132 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 133 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 134 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 154
TABLE 135 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 154
TABLE 136 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 155
11.7 MIDDLE EAST & AFRICA 155
11.7.1 SHORTAGE OF TRAINED PROFESSIONALS TO RESTRAIN THE GROWTH OF THE CELL ANALYSIS MARKET IN THE MIDDLE EAST & AFRICA 155
TABLE 137 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 156
TABLE 138 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 156
TABLE 139 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 156
TABLE 140 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 157
TABLE 141 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 157
TABLE 142 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 158
12 COMPETITIVE LANDSCAPE 159
12.1 OVERVIEW 159
FIGURE 27 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM JANUARY 2018 TO SEPTEMBER 2020 159
12.2 COMPETITIVE SITUATION AND TRENDS 160
12.2.1 PRODUCT LAUNCHES 160
TABLE 143 PRODUCT LAUNCHES 160
12.2.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 160
TABLE 144 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 161
12.2.3 ACQUISITIONS 161
TABLE 145 ACQUISITIONS 162
12.2.4 EXPANSIONS 162
TABLE 146 KEY EXPANSIONS 162
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 163
13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY 163
13.2 COMPETITIVE LEADERSHIP MAPPING 163
13.2.1 STARS 163
13.2.2 EMERGING LEADERS 163
13.2.3 PERVASIVE COMPANIES 164
13.2.4 EMERGING COMPANIES 164
FIGURE 28 LIVE CELL IMAGING MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 164
13.3 MARKET SHARE ANALYSIS 165
FIGURE 29 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 165
13.4 COMPANY PROFILES 168
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.4.1 DANAHER CORPORATION 168
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 168
13.4.2 CARL ZEISS AG 172
FIGURE 31 CARL ZEISS AG: COMPANY SNAPSHOT (2019) 172
13.4.3 NIKON CORPORATION 175
FIGURE 32 NIKON CORPORATION: COMPANY SNAPSHOT (2019) 175
13.4.4 OLYMPUS CORPORATION 178
FIGURE 33 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2019) 178
13.4.5 PERKINELMER INC. 181
FIGURE 34 PERKINELMER INC.: COMPANY SNAPSHOT (2019) 181
13.4.6 SARTORIUS AG 183
FIGURE 35 SARTORIUS AG: COMPANY SNAPSHOT (2019) 183
13.4.7 BIOTEK INSTRUMENTS, INC. 185
13.4.8 THERMO FISHER SCIENTIFIC 187
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 187
13.4.9 ETALUMA, INC. 189
13.4.10 CYTOSMART TECHNOLOGIES 191
13.4.11 NANOENTEK INC. 192
13.4.12 GE HEALTHCARE 193
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2019) 193
13.4.13 BRUKER CORPORATION 195
FIGURE 38 BRUKER CORPORATION: COMPANY SNAPSHOT (2019) 195
13.4.14 BECTON, DICKINSON AND COMPANY 197
FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 197
13.4.15 MERCK KGAA 199
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2019) 199
13.4.16 KEYENCE CORPORATION 201
13.4.17 LOGOS BIOSYSTEMS (ALIGNED GENETICS INC.) 202
13.4.18 NANOLIVE SA 202
13.4.19 SONY BIOTECHNOLOGY INC. 203
13.4.20 PHASE FOCUS LTD. 203
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14 APPENDIX 204
14.1 INSIGHTS FROM INDUSTRY EXPERTS 204
14.2 DISCUSSION GUIDE 205
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 209
14.4 AVAILABLE CUSTOMIZATIONS 211
14.5 RELATED REPORTS 211
14.6 AUTHOR DETAILS 212



★調査レポート[生細胞画像の世界市場予測(~2025):製品別、用途別、技術別、エンドユーザー別] ( Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse Microscopy, FRET) End User (Contract Research Organization, Research Institutes) - Global Forecast to 2025 / BT 3390) 販売に関する免責事項
[生細胞画像の世界市場予測(~2025):製品別、用途別、技術別、エンドユーザー別] ( Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse Microscopy, FRET) End User (Contract Research Organization, Research Institutes) - Global Forecast to 2025 / BT 3390) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆